$TSLATesla , Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits. It provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; and purchase financing and leasing services. This segment is also involved in the provision of non-warranty after-sales vehicle services, sale of used vehicles, retail merchandise, and vehicle insurance, as well as sale of products through its subsidiaries to third party customers; services for electric vehicles through its company-owned service locations, and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners. This segment also offers service and repairs to its energy product customers, including under warranty; and various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla , Inc. in February 2017. Tesla , Inc. was founded in 2003 and is headquartered in Palo Alto, California.
Stockpicks
$XELAExela Technologies, Inc. provides transaction processing solutions, enterprise information management, document management, and digital business process services worldwide. The company operates through three segments: Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal & Loss Prevention Services (LLPS). The ITPS segment provides lending solutions for mortgages and auto loans; banking solutions for clearing, anti-money laundering, sanctions, and interbank cross-border settlement; property and casualty insurance solutions for origination, enrollments, claims processing, and benefits administration communications; and public sector solutions for income tax processing, benefits administration, and records management. It also offers solutions for payment processing and reconciliation, integrated receivable and payables management, document logistics and location services, records management, and electronic storage of data/documents; and software, hardware, professional services, and maintenance related to information and transaction processing automation. The HS segment provides revenue cycle solutions, integrated accounts payable and accounts receivable, and information management for healthcare payer and provider markets. The LLPS segment processes legal claims for class action and mass action settlement administrations, involving project management support, notification, and outreach to claimants; and collects, analyzes, and distributes settlement funds. It also offers data and analytical services in the area of litigation consulting, economic and statistical analysis, expert witness services, and revenue recovery services for delinquent accounts receivable. The company is headquartered in Irving, Texas.
Alpine Income Property Trust, Inc. (Pine) on a strong support Alpine Income Property Trust, Inc. (NYSE: PINE) is a publicly-traded real estate investment trust that acquires, owns and operates a portfolio of high-quality single-tenant net-leased commercial income properties.
I like this title and this support looks interesting and I came in with a small position.
$VGAC Buy the bounce This was has been continuously beat down and its time for a bounce off support. May trade sideways during these red market times
Intel Corp (INTC) rallies, but pay attention to market signaIn the last weeks, this stock has been heavily traded. Many sites talk about title rallies, but....
Technically it's a bullish moment, but the last three days have created a pattern that I don't like. If I had the stock, I'd be careful.
A news by MarketWatch: www.marketwatch.com
A news by FXEmpire: www.fxempire.com
$TGGI Sky Highhhh $TGGI is looking good - a Chinese guy who already established his wine company in China and listed on Chinese stock exchange wants to now list his stock / company on NASDAQ. So he bought TGGI recently.
$TGGI reverse merger play owned my capital intersection LLC (who also owns FTWS and BLUU)
Currently Chinese nanotech wine company wants to use the shell and up list to Nasdaq
$TGGI if it hits a dollar without restructure of SS...200 to 34k
#davidlazar #moody&denuzio #capital intersection
(fm @Tree_Roots)
$TGGI is looking good - a Chinese guy who already established his wine company in China and listed on Chinese stock exchange wants to now list his stock / company on NASDAQ. So he bought TGGI recently.
(fm @Stockslol)
$JFIN appear to be rising on news or speculation regarding NFTsShares of $JFIN appear to be rising on news or speculation regarding NFTs. For those of you that don't know, NFTs are digital files such as art, video, audio, and other files stored on blockchain, which is the digital ledger technology that powers cryptocurrencies like Bitcoin. Some NFTs have already sold for millions of dollars.
Jiayin appear to be linked to speculation that the company may eventually jump into the NFT space.
Jiayin is an online individual loan marketplace that seeks to reach underserved customers in China. However, recent buzz on Twitter has people saying the company could potentially get into the NFT space, although there is no real news pointing to that right now.
The hype and potential around NFT is certainly at an all-time high and eerily reminiscent of when cryptocurrencies, which are also powered by blockchain, first gained mass popularity several years ago.
I would advise caution on anything related to NFTs. While they certainly have taken off in recent months, we are still in very days where the market for these assets will likely remain extremely volatile for quite some time.
www.fool.com
$SNES Announces Successful Completion of ContraPest®SenesTech Announces Successful Completion of a Long Term Agricultural Deployment of ContraPest® with demonstrated, sustained success in reducing rat populations and improving operating economies in poultry settings.
Results from both farms showed a substantial reduction in rats within six months of deployment and continued success as treatment progressed.
finance.yahoo.com
CEMI Technical Analysis 🧙Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
$IMTE stock surged on NFT hype craze$IMTE surged 86% with no apparent reason other than bullish sentiment on social media along with the companies connection potential connection to the non-fungible token craze.
Integrated Media, which says it focuses on glass free 3D display technology, is being touted on social media outlets such as StockTwits and other areas.
seekingalpha.com
$TKAT surged yesterday due to hype in NFT art?The Hong Kong-based online art trading platform rose prompted by increased attention from social media amid frenzy surrounding non-fungible tokens. NFTs are akin to a digital certificate of ownership.
Takung provides collectors a way to jointly own Asian and other fine arts including paintings, calligraphies, jewelry, and precious gems, according to its website.
The hype in NFT art ranging from sneakers to memes have been in the focus of late and a piece from Beeple — “The First 5000 Days” — commanded price tags of millions of dollars.
Tesla Inc TSLA CEO Elon Musk also jumped on the bandwagon and put an NFT song — on NFTs — for sale, which the artist Beeple offered to purchase for $69 million, but later changed his mind.
www.benzinga.com
Banacora LithiumBanacora Lithium (BCN) - London AIM, have reported a 'Lithium deposit with over 200 years of resource life' from 'the world class Sonora Lithium Project in Mexico', producing '17,500-35,000tpa Li₂CO₃ / year' of 'high quality 99.9% lithium'.
In correlation with the demand for lithium, and a current share price of p46.075...
I've already bought, and holding!
$SVRA Announces Closing of $130 Million Public OfferingSavara Announces Pricing of Public Offering of Common Stock
$SVRA today announced the pricing of an underwritten public offering of 45,785,828 shares of its common stock at a price to the public of $1.45 per share.
As a component of the offering, in lieu of shares of common stock, Savara offered to certain existing investors pre-funded warrants to purchase an aggregate of 32,175,172 shares of common stock at a purchase price of $1.449 per warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant.
finance.yahoo.com
Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters’ Option
finance.yahoo.com
NIKE Stock 16/03/21 Analysis 4H ChartNYSE:NKE
- Trend Analysis -
📑Value: 0/20
📈Growth: 18/20
💰Profitability: 20/20
🚀Momentum: 8/20
💸Earnings: 16/20
🖇️Total Score: 62/100
Analysis:
Low: $41
Average: $72.83
High: $105
Current: $72.96
Data:
Volume 3.74M
Average Volume (3 months) 5.71M
Previous Close $144.94
Open $145.88
Shares Outstanding 1.27B
Technicals:
(Simple Moving Average)
10D SMA $137.13 (+5.55%)
50D SMA $139.63 (+3.67)
200D SMA $122.39 (+18.27%)
Market Cap $221.42B
Total Debt $12.80B
Cash $11.81B
Enterprise Value $222.41B
Dividend Yield 0.76%
Annual Payout $1.10
Payout Ratio 36.88%
Years of Growth 19 Years
Latest Announced Dividend $0.28
Ex-Dividend Date 26/02/2021
Payout Date 01/04/2021
Revenue $38.25B
Gross Profit $16.44B
Net Income $2.83B
EPS Diluted $1.77
Free Cash Flow / Share $2.32
$QS PT 120 and higherQuantumScape, a developer of what are known as solid-state batteries, has entered into a definitive agreement to merge with blank check company Kensington Capital Acquisition Corp. EV battery manufacturer backed by Bill Gates and Volkswagen. Implied Value of combined companies is $3.3B
QuantumScape Corporation engages in the development and commercialization of solid-state lithium-metal batteries for electric vehicles. The company was founded in 2010 and is headquartered in San Jose, California
DKNG Stock 12/03/21 Analysis 4H Chart(DRAFTKINGS: DKNG )
- Trend Analysis -
📑Value: 0/20
📈Growth: 14/20
💰Profitability: 14/20
🚀Momentum: 20/20
💸Earnings: 14/20
🖇️Total Score: 62/100
Analysis:
Low: $41
Average: $72.83
High: $105
Current: $72.96
Income Statement:
Revenue: $614.53M
Gross Profit: $267.94M
EBITDA: -----
Net Income: -----
EPS Diluted: -$2.76
Cash Flow Statement:
Cash from Operations: -$337.88M
Cash from Investing: -$227.34M
Levered Free Cash Flow: -$49.38M
Unlevered Free Cash Flow: -$48.72M
Free Cash Flow: -$1.26
Balance Sheet:
Total Cash: $1.82B
Total Debt: $81.61M
Total Debt to Equity: 3.03%
Current Ratio: 3.96
Quick Ratio: 3.96
$SEEL PT 90 and higherSeelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorder and post-traumatic stress disorder; SLS-005, a protein stabilizer for the treatment of Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.